Company ProfilePremium

NutryFarm International Limited

Company Profile Analysis

Ticker: AZT.SI

ESOMAR 23 Corporate BadgeISO Certifications Badge
NutryFarm International Limited - Company showcase

Year Founded & Workforce

2002

29 Employees

NutryFarm International Limited logo

NutryFarm International Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

NutryFarm International Limited Overview

NutryFarm International is a Bermuda-incorporated, SGX-Mainboard shell-in-transformation. For most of the past decade it was a Chengdu-based maker of herbal nutrition and health-food products, sold through its subsidiary NutryFarm (Chengdu) Biomedicine. In 2021 it made a short-lived, contentious diversification into Thai durian trading. Governance failures, impaired related-party advances and an unpayable debt load then pushed it into court-supervised judicial management from June 2022 to February 2026. The legacy operating businesses have been disposed of or deconsolidated. The group is now attempting a reverse-turnaround into AI and data-centre infrastructure through its subsidiary AI Nova Pte. Ltd., which offers cloud GPU, connectivity and data-centre consultancy services across Singapore, Malaysia, Indonesia and China. AI Nova reports a contract pipeline of about US$400M and a US$65.2M customer receipt in September 2026. The equity case depends on SGX approving resumption, a highly dilutive creditor debt-for-equity conversion, and verification of a single, undisclosed anchor customer.


The company's own description (latest annual report)

The FY2024 Annual Report describes the company as a Bermuda-incorporated investment holding company listed on the SGX Mainboard. It says the company is repositioning, after restructuring under judicial management, as a diversified platform in technology infrastructure (AI and data centres) across Southeast Asia and China [AR24]. The FY2023 Annual Report, published two months earlier, also included agri-commodities trading in this description. That element was dropped from the FY2024 wording [AR23 vs AR24].

The CEO's message in the FY2024 AR says AI Nova's core activities are:

  • Cloud GPU services

  • Enterprise connectivity solutions

  • Service-based operations

  • Data-centre consultancy, including AI consulting, Internet Data Centre (IDC) consulting and managed services

It cites a contract pipeline of approximately US$400 million. It also says the group is pursuing data-centre operations and infrastructure projects in Singapore, Malaysia, Indonesia and the PRC [AR24].

Independent characterisation

Business model, current. AI Nova is best described as an asset-light reseller and integrator of high-performance cloud computing capacity, not yet an owner-operator of data centres. Monthly updates from October 2025 describe several elements:

  • AI Nova's new business segments: high-performance computing equipment leasing, data-centre and warehouse operation and maintenance, and Singapore telecommunications services [MC, 29 Oct 2025]

  • A first service agreement (24 June 2025) to supply cloud computing and maintenance services

  • A second service agreement (25 July 2025) to supply cloud, maintenance and support services to a third-party customer

  • A parent-company continuing guarantee (2 September 2025) in favour of the upstream service provider

Together these point to a back-to-back structure. AI Nova contracts capacity from an upstream provider, with a parent guarantee, and resells it to an end customer. Margin capture depends on the spread between the two contracts. Neither counterparty has been publicly identified [MC, 7 Oct 2026].

Revenue model. The model is service and contract-based, with multi-year terms. The main services agreement was extended to 60 months, ending 30 November 2030 [MC, 7 Oct 2026]. This resembles infrastructure-as-a-service subscription revenue. No product, licensing or subscription mix has been disclosed. FY2024 group revenue was nil [AR24].

Value-chain position. AI Nova sits in the middle of the chain. Upstream are GPU and server owners and data-centre operators. Downstream are enterprise or AI customers.

Customer types and end-markets. The company targets enterprise AI and cloud workloads in Southeast Asia and China. Customer identities and creditworthiness are not publicly disclosed [MC, 7 Oct 2026].

Legacy model, through FY2022. NutryFarm (Chengdu) Biomedicine (NFC) operated 34,165.33 square metres of facilities in Sichuan. It researched, manufactured and marketed more than 40 self-manufactured nutrition and health-food products formulated from traditional medicinal herbs for PRC consumers [AR19]. From December 2020 the group also traded Thai fresh durians into China through Global Agricapital entities [PR, 17 Mar 2021]. NFC was disposed of in April 2023. FTI reported that this disposal was not authorised by the judicial manager [RegCo].

Strategy

Stated strategy (FY2024 AR themes, paraphrased)

  • Pivot to technology infrastructure, AI-related services and digital transformation across the region through AI Nova. Management cites demand for AI computing, cloud infrastructure and data localisation.

  • Build on the ~US$400M AI Nova contract pipeline, aiming for recurring revenue.

  • Develop and expand data-centre operations and infrastructure projects in Singapore, Malaysia, Indonesia and the PRC.

  • Resume trading on SGX through the ROTP, re-submitted 30 June 2025.

  • Restructure creditor obligations through debt conversion, disposal of distressed subsidiaries and assignment of rights to use.

  • Emphasise financial prudence, governance and rebuilding stakeholder confidence.

Source: [AR24].

Initiative register (last 24 months)

DateInitiativeDetailSource
12 Sep 2024Rebrand subsidiary to AI NovaPlatform for new businesses[JM 11 Nov 2024]
10 / 14 Oct 2024Alpha Hill S$5M loan and Corpbond supplementary deedS$1.5M to AI Nova; S$0.3M for resumption costs; S$3.2M general working capital. Corpbond bears up to S$1M of resumption costs[AR24]
9 Apr 2025 (addendum 10 Oct 2025)Implementation Agreement with CorpbondConversion shares, disposal of distressed subsidiaries, assignment of rights to use. Requires SGX, SIC and shareholder approvals[AR24]
24 Jun / 25 Jul 2025Cloud services agreementsFirst commercial contracts[MC 29 Oct 2025]
Jul–Oct 2025AI Nova convertible loansUS$0.5M, 3 × US$5M and up to US$3M facilities at 7%, convertible at S$0.045[AR24]
2 Sep 2025Parent continuing guaranteeSecures AI Nova obligations to its service provider[MC 29 Oct 2025]
7 Oct 2025Updated Forecast Memorandum to SGXReflects the changed AI Nova business model[AR24]
28 Oct 2025 / 28 Jul 2026SCA, then amended SCATranche 1 S$27.37M at S$0.022 (pre-resumption). Tranche 2 S$6.90M at up to a 10% discount to post-resumption VWAP. Long-stop date 31 Dec 2026[AR24], [MC 31 Jul 2026]
Jul 2026Amended restructuring agreements; termination of US$1M loan agreementsStated to have no material EPS/NTA impact[MS], [MC 31 Jul 2026]
Apr–Sep 2026Subsidiary build-outDC Green Development, AIDC Investor, HyperEdge Global, a PRC subsidiary and three others[Ann 22 Apr 2026], [TR], [MS]
7 Sep 2026Third amendment to services agreementTerm extended to 60 months; ~US$65.205M received[MC 7 Oct 2026]

Medium-term financial targets / guidance: none published. A Forecast Memorandum was submitted to SGX but has not been publicly released.

ESG commitments and cost-programme targets: none disclosed.

Products & Services

Current portfolio (AI Nova and related entities)

OfferingDescriptionTarget customerLaunchPricing modelSource
Cloud GPU / high-performance cloud computing servicesSupply of cloud-based computing capacity, maintenance and supportEnterprise / AI workload customers (unnamed)First service agreement 24 Jun 2025; second 25 Jul 2025Multi-year contract. Main agreement extended from 36 to 60 months (to 30 Nov 2030); ~US$65.205M received 30 Sep 2026. Unit pricing not disclosed[MC 29 Oct 2025], [MC 7 Oct 2026]
HPC equipment leasingLeasing of high-performance computing equipmentEnterpriseBusiness segment added Oct 2025—[MC 29 Oct 2025]
Data-centre and warehouse operation & maintenanceO&M servicesDC owners / operatorsOct 2025—[MC 29 Oct 2025]
Telecommunication services (Singapore)Voice, data and value-added services for enterprise and individual usersSingapore enterprise and retailOct 2025—[MC 29 Oct 2025]
Enterprise connectivity solutionsNetwork connectivityEnterpriseDisclosed 2026—[AR24]
AI consulting / IDC consulting / managed servicesAdvisory on AI and internet data centres, plus managed servicesDC developers, enterprisesDisclosed 2026—[AR24]
Technical testing and analysis, including product and service certificationTesting services—Principal activity added Sep 2024—[AR23]
Wholesale trade (non-dominant products)General trading—Added Sep 2024—[AR23]
Data-centre development (DC Green Development, AIDC Investor, HyperEdge Global)Vehicles for DC-related investment and projects in Singapore, Malaysia, Indonesia and PRC—2,026—[AR24], [Ann 22 Apr 2026], [TR]

No named product brands, platforms, GPU models, megawatt capacity or locations have been disclosed for any of these offerings.

Legacy portfolio (discontinued / disposed)

LineDescriptionStatusSource
Nutrition and health-food productsMore than 40 self-manufactured products formulated mainly from traditional medicinal herbs from the Americas, China, Europe and New Zealand, sold to PRC consumers under the "Nutrition for health" philosophyDisposed with NFC, Apr 2023[AR19]
Fresh durian trading (Thailand → China; Singapore retail JV)Containerised fresh durian sourcing and sale. Orders included ~RMB130M for 200 containers fulfilled by 30 Apr 2021 and ~RMB195M for 300 containers in Jun 2021; Kong Jun Durian JV in SingaporeWound down; subject of litigation[PR], [Edge]
Internet management / WebTV technical supportLottVision-era internet services in ChinaLegacy[Mkt: Morningstar]
Digital video surveillance productsLottVision-era productsLegacy[Mkt: Yahoo profile]

Financial Narrative

Basis. All figures are in HK$ thousand unless stated. FY2020 is an 18-month period (1 Apr 2019 – 30 Sep 2020). FY2021, FY2023 and FY2024 are 12 months to 30 September. FY2022 figures are as restated in the FY2023 AR, which moved the legacy business to discontinued operations. FY2020 and FY2021 figures are as originally presented in the FY2021 AR, before the discontinued-operations reclassification. Every year carries an auditor's disclaimer of opinion. Sources: FY2020–FY2021 [AR21]; FY2022–FY2023 [AR23]; FY2024 [AR24].

Income statement

FY2022 EPS is the sum of continuing (−48.51) and discontinued (−11.06) cents [AR23].

EBITDA. Depreciation and amortisation were disclosed for FY2020 (HK$3,833k) and FY2021 (HK$2,616k) only. That gives derived EBITDA of HK$-30,171k for FY2020 and HK$-98,125k for FY2021 [AR21]. Continuing-operations D&A is not disclosed for FY2022–FY2024. With a fixed-asset base of HK$22k–25k in FY2023–FY2024, EBITDA approximately equals EBIT in those years.

Margins. Margins can be computed only for years with revenue.

Revenue CAGR. A five-year CAGR is not meaningful. The base periods differ (an 18-month FY2020) and revenue falls to nil in FY2022 (restated) and FY2024. For the longer arc, see the legacy series below.

Legacy context. These are 12-month periods to 31 March, from the results announcements.

Sources: [R-FY18], [R-FY19]. The 12 months to 31 March 2020 recorded revenue of HK$37,820k [R-Q4FY20].

Commentary: trends, inflections and drivers.

  1. Structural revenue decline, then collapse. Legacy nutrition revenue fell from HK$79.1M (FY2017) to HK$44.0M (FY2019). FY2021 revenue rose to HK$99.0M, partly because 2021 was the first full year of fruit trading. However, the FY2021 results were prepared after removing all Thai durian transactions overseen by the former CEO [R-FY21], [R-1Q22]. That is notable, because the company had publicly announced fulfilling ~RMB130M of durian orders by April 2021 alone [PR 21 Jun 2021]. Investors should regard the FY2021 top line as heavily adjusted.

  2. Impairments drove the losses, not operations. Credit impairments of HK$98.6M in FY2021 and HK$35.1M in FY2022 explain most of the losses. These map to the Wang Xiaoxin advances (HK$59.8M still owed at 31 March 2022) and MLTY loans (RMB18.1M owed at 30 September 2021) identified by FTI [RegCo]. FY2021 gross profit of HK$30.8M shows the legacy business was still viable at the gross level.

  3. Interest burden is now the whole P&L. In FY2024, finance costs of HK$15.2M equalled 103% of the net loss. Administrative costs fell 88% to HK$3.2M as the group shrank to a holding shell. The tiny positive EBIT of HK$427k in FY2024 comes from HK$3.6M of "other income", not operations.

  4. The inflection is ahead. FY2025 (from June 2025 service agreements) and FY2026 (US$65.2M receipt in September 2026) should show the first AI Nova revenue. Neither has yet been reported. The receipt's accounting treatment (revenue, deferred revenue/contract liability, or financing) has not been disclosed.

Balance sheet

Goodwill and intangibles: HK$567k (FY2020) and HK$640k (FY2021); nil in FY2023–FY2024. The FY2022 intangible balance is not shown in the FY2023 AR highlights [AR21], [AR23], [AR24].

Commentary.

Assets largely gone: By FY2023 the group had shed essentially all assets. The NFC disposal removed PPE, inventories and receivables, leaving total assets of HK$1.0M against liabilities of HK$204.7M.

Corpbond is the core liability: Borrowings are dominated by the Corpbond facility. The October 2025 SCA sizes the debt owed to Corpbond at S$33.5M (principal plus interest to 30 June 2025), plus S$0.77M of assigned minority-creditor claims [AR24].

Parent-level deficit: At company level, net liabilities were HK$281.5M at FY2024 [AR24].

Post-balance-sheet changes: The FY2024 position predates the following:

  • The S$5M Alpha Hill loan (fully drawn)

  • AI Nova third-party loans: US$0.5M, three loans of US$5M each, and US$2M drawn of a US$3M facility, all at 7% and convertible at S$0.045 [AR24]

  • The ~US$65.2M customer receipt [MC 7 Oct 2026] The FY2025 and FY2026 balance sheets will therefore look very different.

Cash flow

Commentary.

FY2021 was funded by equity: The HK$41.3M of 2021 placement proceeds lifted year-end cash to HK$48.3M [AR21].

That cash then left the group: It drained through FY2022 operating outflows (HK$27.3M) and the FY2023 deconsolidation outflow (HK$33.7M) [AR23].

Minimal funding since: FY2023–FY2024 were funded by small third-party and related-party loans of HK$2–4M a year.

Ratios

All ratios are analyst-computed from the AR figures above.

Not meaningful:

Return metrics: ROE and ROIC: equity has been negative since FY2021, and invested capital is negative.

Leverage multiples: Debt/equity: 18.8x in FY2020, negative equity thereafter. Net debt/EBITDA: EBITDA is negative.

Cash conversion cycle: Revenue is too small or nil to support it.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Era Details

EraReported segmentsNotesSource

FY2018–FY2021

(1) Internet Management: technical support for internet/WebTV; (2) Investment Holding: group investments and treasury; (3) Nutrition, Health Food & Related Health Products: manufacturing and trading, key revenue driver; (4) Fruits & Related Products: durian trading, added FY2021

Revenue mostly PRC-derived; operations in Singapore, PRC, Thailand

[Mkt: Morningstar], [AR21]

FY2022–FY2023 (restated)

Continuing operations vs discontinued operations. The legacy nutrition business (NFC) and other distressed subsidiaries were reclassified as discontinued. FY2022 comparatives were restated: FY2022 continuing revenue is nil

NFC disposed Apr 2023

[AR23]

FY2024

Single continuing group with nil revenue; AI Nova pre-revenue

No segment revenue disclosed

[AR24]

FY2026 (prospective)

Technology infrastructure: Cloud GPU, connectivity, data-centre consultancy (AI Nova and the AIDC Investor / HyperEdge Global / DC Green Development entities)

Not yet reported

[AR24], [TR]

Results by Segment

MetricFY2022FY2023FY2024

Continuing operations revenue (HKD K)

04,0800

Continuing operations gross profit (HKD K)

02190

Continuing operations loss before tax (HKD K)

-65,657-40,599-14,805

Discontinued operations loss (HKD K)

-15,797-28,9960

Total loss (HKD K)

-81,454-69,595-14,805

Group Entities

EntityJurisdictionFunction / statusSource

AI Nova Pte. Ltd. (formerly Global Agricapital (Singapore) Pte. Ltd.)

Singapore

Core operating subsidiary: cloud GPU, connectivity, DC consultancy; S$1.5M capital injection 25 Oct 2024

[AR24]

AI Nova Sdn Bhd

Malaysia

MoU with Asas Panorama Sdn Bhd (aggregator-reported; terms not disclosed)

[Mkt: roic.ai]

DC Green Development Pte. Ltd.

Singapore

Incorporated 22 Apr 2026, S$10,000 capital; directors Niu Liming and Tan Chui Eng

[Ann 22 Apr 2026]

AIDC Investor Pte. Ltd.

Singapore

Incorporated 7 Jul 2026, S$10,000; directors Tan Chuan-Jin and Tan Chui Eng

[TR 15 Jul 2026]

HyperEdge Global (Pte. Ltd.)

Singapore

Wholly owned by AIDC Investor; modest capital

[TR 15 Jul 2026]

—

PRC

Incorporated Aug 2026

[MS]

——

Formed Sep 2026

[MS]

Global Agricapital (Thailand) Co., Ltd (GAT)

Thailand

Legacy durian unit; plaintiff against former CEO Cheng Meng in Bangkok

[AR24]

LottVision (Hong Kong) Limited

Hong Kong

Guarantor of the 2017 Corpbond facility (legacy)

[Ann 30 Oct 2017]

Lottvision Internet Management Ltd (China)

PRC

Legacy internet-management unit

[JM 2 Dec 2022]

NutryFarm (Chengdu) Biomedicine / Agricultural Technology Co. (NFC)

PRC

Disposed Apr 2023

[RegCo], [AR23]

“—” = not publicly disclosed.

Income Statement and Per-Share Data

MetricFY2020FY2021FY2022FY2023FY2024

Revenue (HKD K)

61,56898,99504,0800

Cost of sales (HKD K)

-39,692-68,2140-3,8610

Gross profit (HKD K)

21,87630,78102190

Net impairment losses on financial assets (HKD K)

-9,629-98,600-35,054-1,4020

Administrative expenses (HKD K)

-40,840-28,412-21,298-26,397-3,219

Finance costs (HKD K)

-14,796-9,891-12,000-14,967-15,232

Operating income, EBIT (HKD K; analyst-derived as PBT + finance costs − interest income)

-34,004-100,741-53,657-25,633427

Loss before tax, continuing (HKD K)

-48,394-110,528-65,657-40,599-14,805

Net loss, total (HKD K)

-48,512-111,453-81,454-69,595-14,805

EPS basic and diluted (HK cents)

-50.31-97.90-59.57-50.63-10.77

Dividends per share (HK cents)

00000

Margin Analysis (%)

MetricFY2020FY2021FY2023

Gross margin (%)

35.531.15.4

EBIT margin (%)

-55.2-101.8-628.3

Net margin (%)

-78.8-112.6-1,705.8

Income Statement

MetricFY2017FY2018FY2019

Revenue (HKD K)

79,05366,89644,042

Profit or loss before tax (HKD K)

3,118-7,824-89,700

Net profit or loss (HKD K)

1,527-8,280-91,593

Balance Sheet

MetricFY2020FY2021FY2022FY2023FY2024

Total assets (HKD K)

184,812135,87894,6451,0141,858

Cash and bank balances (HKD K)

8,68948,29034,42348620

Short-term borrowings (HKD K)

55,06897,848153,106148,065159,231

Long-term borrowings (HKD K)

83,54543,594000

Total borrowings (HKD K)

138,613141,442153,106148,065159,231

Net debt (HKD K)

129,92493,152118,683148,017158,611

Trade and other payables (HKD K)

36,81750,80670,50256,60374,690

Total liabilities (HKD K)

177,457196,598228,123204,672233,921

Total equity or deficit (HKD K)

7,355-60,720-133,478-203,658-232,063

Working capital (HKD K)

42,598-34,262-148,536-203,699-232,092

Property, plant and equipment (HKD K)

46,58215,29413,9862522

Inventories (HKD K)

8,00816,64215,30000

Cash Flow

MetricFY2020FY2021FY2022FY2023FY2024

Operating cash flow (HKD K)

3,346-3,404-27,340-4,706-2,181

Capital expenditure (HKD K)

16,8613,0919110

Free cash flow (HKD K)

-13,515-6,495-27,349-4,717-2,181

Dividends paid (HKD K)

00000

Share buybacks (HKD K)

00000

Equity issuance proceeds (HKD K)

041,299000

Net financing cash flow (HKD K)

-12,29438,57516,7794,0702,753

Financial Ratios (x)

MetricFY2020FY2021FY2022FY2023FY2024

Current ratio (x)

1.450.780.350.0050.008

Interest coverage, EBIT over finance costs (x)

-2.30-10.19-4.47-1.710.03

Net debt to total assets (x)

0.700.691.25145.9785.37

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2021FY2022FY2023FY2024

ROA on average total assets (%)

-69.5-70.7-145.5-1,031.0

Asset turnover on average total assets (x)

0.620.000.090.00

Revenue by Region

MetricFY2021FY2022FY2023FY2024

Group revenue, all regions (HKD K)

98,99504,0800

Region Overview

RegionHistoric roleCurrent / prospective roleTrend

PRC (Sichuan / Chengdu)

Manufacturing and sales of nutrition products; durian import destination

NFC disposed Apr 2023; AI Nova targets PRC DC projects; new PRC subsidiary Aug 2026

Declined to nil; may re-emerge

Thailand

Durian sourcing via GAT

Litigation only (Bangkok South Civil Court)

Declined to nil

Singapore

Listing venue; Kong Jun durian JV

AI Nova HQ, telecom services, DC Green Development, AIDC Investor, HyperEdge Global

Fastest-growing (from zero)

Malaysia

—

AI Nova Sdn Bhd; MoU with Asas Panorama Sdn Bhd

Emerging

Indonesia

—

Targeted DC projects

Prospective

Hong Kong

Principal office

Office relocated to Singapore by FY2024 AR

Declined

Data Point Details

Data pointValueDateSource

Last traded price

0.085

Before suspension on 11 Apr 2022

[Mkt], [Edge]

All-time high

0.510

22 Jun 2021

[Mkt: TradingView]

All-time low

0.031

31 Mar 2020

[Mkt: TradingView]

Sharp drop before suspension

0.22 → 0.14 (−36.4%) on 221% higher volume

Early 2022, cited by SGX RegCo

[Edge]

Placement price

0.29

Jun 2021

[Edge]

SCA Tranche 1 conversion price

0.022

Oct 2025

[AR24]

AI Nova loan conversion price

0.0452025

[AR24]

Alpha Hill loan conversion price

0.015

Oct 2024

[AR24]

Share Count (millions)

MetricFY2020FY2021FY2022FY2023FY2024

Shares outstanding at year-end (millions)

96.42137.42137.42137.42137.42

Dividends per share (HK cents)

00000

Capital Instruments

InstrumentAmountMaturityTermsSource

Corpbond debt (2017 facility plus assigned claims)

S$34.27M

To be converted (long-stop 31 Dec 2026)

Tranche 1 S$27.37M at S$0.022; Tranche 2 S$6.90M post-resumption

[AR24], [MC]

Alpha Hill loan

S$5.0M

5 years from disbursement (~2029)

Interest-free; convertible at S$0.015

[AR24]

AI Nova loan

US$0.5M

2 years (~2027)

7%; convertible at S$0.045

[AR24]

AI Nova loans

US$5.0M + US$5.0M + US$5.0M

1, 2 and 3 years (~2026–2028)

7%; convertible at ≤S$0.045

[AR24]

AI Nova loans (3 × US$1M)

US$2M drawn

2 years (~2027)

7%; US$1M facility terminated Jul 2026

[AR24], [MC]

Analyst Conclusions

Management guidance: none published. The Forecast Memorandum submitted to SGX (7 October 2025) has not been released. Management frames the outlook around the ~US$400M pipeline and regional DC expansion [AR24].

Consensus growth expectations: none; no analyst coverage.

Bull case

  1. Contracted cash is real. The US$65.2M receipt and 60-month term to 2030 suggest a counterparty with genuine demand and recurring revenue potential against a ~S$12M market cap [MC 7 Oct 2026].

  2. Balance sheet can be reset. Converting S$34.27M of Corpbond debt plus the convertible loans would remove nearly all of the HK$159M borrowings, leaving a clean, listed AI-infrastructure vehicle [AR24].

  3. Credible board, real growth market. The board now has relevant cloud and finance credentials, and the Malaysian DC market is projected to nearly double by 2031 [AR24], [Ind].

Bear case

  1. Unverifiable economics. Five consecutive audit disclaimers, an undisclosed customer and an unexplained receipt mean the core economics cannot be verified [AR24], [MC].

  2. Minorities are crowded out. Tranche 1 conversion at S$0.022 (74% below the last trade) gives the converting creditor ~90% before other conversions [AR24].

  3. Governance contest unresolved. The CEO's Corpbond affiliation, an open SGX RegCo investigation and an active SGM/proxy dispute signal unresolved control conflict [AR24], [RegCo], [TR].

Catalysts and monitorables (next 12 months)

SGX decision on the ROTP: This determines whether trading resumes.

Restructuring completion by 31 Dec 2026: SCA long-stop date, plus SIC whitewash and shareholder approvals.

Outstanding accounts: Publication of FY2025 and FY2026 accounts, including the accounting treatment of the US$65.2M receipt and whether the disclaimer is lifted.

The requisitioned SGM: Its outcome on board and CEO changes.

Investigations and litigation: Progress of the SGX RegCo investigation and the High Court claim.

Business disclosures: Any naming of the customer or upstream provider, MW capacity, and DC project sites in Malaysia, Indonesia or the PRC.

Analyst verdict.

NutryFarm International is no longer the herbal-supplements company its name implies. It is a post-insolvency listed shell being repurposed, under creditor sponsorship, into an AI cloud and data-centre services vehicle. The historical record is poor:

  • A decade of revenue decline in the legacy business

  • HK$98.6M of FY2021 credit impairments traced to undocumented, interest-free advances

  • A durian venture whose transactions had to be stripped out of the accounts

  • Allegedly unauthorised settlement agreements worth RMB334M

  • A disposal of the main subsidiary that the judicial manager did not authorise

SGX RegCo's December 2025 judgement that governance fell short of expected standards is fair.

The transformation, however, is not imaginary. Judicial management ended in February 2026. Minority creditor claims were consolidated into a single creditor. A reconstituted board includes genuine cloud expertise. Most strikingly, AI Nova received about US$65.2M from a customer under a contract extended to 2030. If the receipt and margins are verified, the operating subsidiary could quickly dwarf the parent's liabilities.

The difficulty is the gap between those signals and auditable fact. No set of accounts since FY2019 carries a clean opinion. The customer, the supplier and the margin structure are undisclosed. The parent guarantees the upstream supplier, and FY2025 numbers are outstanding. For existing minority shareholders, the capital structure is decisive. Conversion at S$0.022, against a last trade of S$0.085, transfers roughly nine-tenths of the equity to the creditor group led by entities the CEO is associated with. That happens before the Alpha Hill (S$0.015) and AI Nova (S$0.045) conversions.

Verdict: a high-risk, binary special situation, uninvestable on fundamentals until three things happen: (1) SGX approves resumption on the basis of audited, unqualified accounts; (2) the anchor contract's counterparty and economics are disclosed; and (3) the October 2026 control dispute is resolved. Equity value for current holders is likely to be heavily diluted even in the success case.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameTitleAppointedCommitteesBackground

Niu Liming

Executive Director and CEO

19 Dec 2022; re-appointed 5 Dec 2025 and 31 Mar 2026

NC, RC member

Director of Corpbond Holdings Pte Ltd and Corpbond Investments Pte Ltd (Corpbond is the company's largest creditor and JM applicant). 20+ years in M&A, restructuring, private equity. MBA (Strathclyde), MSc (Chinese Academy of Sciences), BSc (Qingdao University). Age not disclosed

Wan Tai Foong

Lead Independent Director

31 Mar 2026

AC Chair; NC, RC

25+ years in investment banking (Rabobank International, KCB Bank Singapore, Kim Eng Corporate Finance, N M Rothschild & Sons Singapore; started at Arthur Andersen). Founder and CEO of Qi Capital Pte Ltd. BCom (Murdoch), CPA Australia

Er Kwong Wah

Independent Director

23 May 2023; re-appointed 2025 and 2026

NC Chair; AC, RC

27 years in Singapore civil service; former Permanent Secretary (Education, then Community Development). Former directorships at Sembawang Marine & Logistics, Sembcorp Industries, COSCO Shipping International (Singapore); currently ID of Luxking Group and Metech International. BASc (Toronto), MBA (Manchester)

Ng Chern Nee

Independent Director

5 Dec 2025; re-appointed 31 Mar 2026

RC Chair; NC, AC

30+ years in AI, cloud, cybersecurity, telecoms. Former MD (Singapore & Malaysia) Google Cloud; GM Public Sector, Microsoft Asia Pacific; founder of Singlife Philippines. BBA (NTU)

Executive Leadership Team

NameRoleSinceSource

Niu Liming

CEO

Dec 2022

[AR24]

Derek Ong Chee Beng

Group Financial Controller (age 60 per aggregator)

8 Jun 2026

[MS]

Tan Chui Eng

Director of DC Green Development and AIDC Investor (subsidiary level)

2026

[Ann 22 Apr 2026], [TR]

Tan Chuan-Jin

Director of AIDC Investor Pte. Ltd. (subsidiary level)

Jul 2026

[TR 15 Jul 2026]

Virtus Law LLP

Company Secretary

3 Mar 2025

[AR21]

Board & Management Changes

DateChangeSource

14 Oct 2019 / 6 Feb 2020

Terence Luk becomes ED, then CEO

[AR21]

6 Jan 2021

Cheng Meng becomes CEO; Luk re-designated Non-Executive Chairman

[AR21]

30 Dec 2021

Xu Hai Min resigns as NED

[AR21]

11 Feb 2022

Cheng Meng steps down as CEO (remains ED to 1 Apr 2022)

[AR21]

Mar–Oct 2022

Neo Chee Beng (1 Mar), Lee Pih Peng (21 Mar), Ng Poh Khoon Jimmy (23 Sep), Terence Luk (3 Oct) and Lim Swee Hua David (12 Oct) resign

[AR21], [AR23]

May 2022

Wu Yongqiang signs results as Executive Chairman; later resigns (Edge reports chairman's resignation)

[R-FY21], [Edge]

19 Dec 2022

Niu Liming appointed ED/CEO; Ng Fang Yao and Luo Shi Yao cease

[AR23]

23 May 2023

Er Kwong Wah, Hwang Kin Soon Ignatius and Seah Chee Wei appointed

[AR23]

Jan / Mar 2024

Seah Chee Wei (15 Jan) and Hwang (10 Mar) cease

[AR24]

5 Dec 2025

Goodchild, Ng Chern Nee and Kelvin Chow appointed

[AR23]

31 Mar 2026

Wan Tai Foong appointed Lead ID

[AR24]

9 Oct 2026

Shareholders (≥10%) requisition an SGM to remove a director, appoint In Nanny Sing Charlie and potentially change the CEO

[TR 9 Oct 2026]

Competitive Landscape

Competitors by Segment

SegmentCompetitorRelevance / scale (where sourced)Source

AI cloud / sovereign AI, Malaysia

YTL Power International (YTL AI Cloud)

Strategic agreement with NVIDIA valued at RM10B (~US$2.36B) for AI data centres; Johor campus of up to 72MW

[Ind: DCD, w.media]

GPU-as-a-service, Malaysia

IP ServerOne (NovaGPU)

Managed GPUaaS with Malaysian data residency; Sarawak region live

[Ind: IPServerOne]

AI compute centres, Malaysia

Malton Bhd / Ricloud AI (NVIDIA Cloud Partner)

MoU to build AI compute centres

[Ind: BusinessToday MY, FocusMalaysia]

APAC neocloud

Sharon AI (Nasdaq: SHAZ)

US$1.32B five-year cloud compute contract with a global AI lab; 132MW AI-factory capacity

[Ind: BusinessWire]

Hyperscale cloud

Amazon Web Services, Microsoft Azure, Google Cloud

Dominant regional cloud providers (scale figures not sourced here)

General industry knowledge

SEA data-centre operators

ST Telemedia Global Data Centres, Princeton Digital Group, AirTrunk, Singtel (Nxera), Keppel DC

Major DC landlords and operators (figures not sourced here)

General industry knowledge

Legacy: PRC nutrition supplements

By-health, Tomson and other PRC health-food makers

Historical only

General industry knowledge

Peer Comparison FY2024

MetricNutryFarm (FY2024)YTL PowerSharon AIIP ServerOne

Revenue

HK$0

——

Private: not publicly disclosed

Flagship AI contract

Undisclosed customer; ~US$65.2M received; 60-month term

RM10B NVIDIA partnership

US$1.32B, 5 years

—

Owned DC capacity

None disclosed

Up to 72MW (Johor campus)

132MW AI-factory capacity

Multiple Malaysian regions

Gross margin / R&D intensity

Not meaningful / not disclosed

———

Balance sheet

Net liabilities HK$232.1M

Large-cap utility group

Raised US$1.6B in 2026

Private

“—” = not publicly disclosed.

Recent Developments

--

Company Snapshot

29

Employees

2002

Founded

Hamilton HM, Bermuda

Headquarters

SWOT Analysis

Strengths

  • Discharged from JM. Board powers were restored on 2 February 2026 after ~43 months of judicial management [AR24].
  • Legacy creditor claims resolved. Minority creditors were paid 20% in cash on 29 August 2024 and assigned their claims to Corpbond, leaving essentially one major creditor [AR24].
  • Anchor contract. The term was extended to 60 months (to 30 November 2030), and ~US$65.2M was received around 30 September 2026. That is roughly 280x the group's FY2024 total assets (US$65.2M vs HK$1.86M ≈ US$0.24M) [MC 7 Oct 2026], [AR24].
  • Relevant board expertise. The independent directors include an ex-Google Cloud MD (Ng Chern Nee) and an investment banker as AC chair (Wan Tai Foong) [AR24].
  • Lean cost base. FY2024 administrative expenses were only HK$3.2M, down 88% year on year [AR24].
  • Disclosed pipeline. Management cites ~US$400M of contract pipeline [AR24].

Weaknesses

  • Disclaimers every year. All accounts from FY2020 to FY2024 carry auditor disclaimers [AR21], [AR23], [AR24].
  • Deep insolvency on the balance sheet. Group net liabilities were HK$232.1M and current ratio 0.008x at FY2024 [AR24].
  • No reported revenue. Revenue in the new business was nil in FY2024 [AR24].
  • Customer opacity. The customer, its creditworthiness and the economics of the US$65.2M receipt are undisclosed [MC 7 Oct 2026].
  • Governance legacy. FTI found disbursements of up to HK$91.4M to a vendor without board resolution, and loans to MLTY with no commercial justification [RegCo].
  • Thin finance function. A Group FC was appointed only in June 2026, and no CFO is disclosed [MS].

Opportunities

  • SGX resumption. Resumption would restore liquidity and the ability to raise equity. The ROTP has been under review since 30 June 2025 [AR24].
  • Market growth. The Malaysian DC market is projected to nearly double to US$11.4B by 2031 [Ind].
  • Regional build-out. DC project vehicles have been incorporated in Singapore and the PRC (DC Green Development, AIDC Investor, HyperEdge Global) [TR], [Ann].
  • Litigation recovery. The High Court claim seeks HK$91.4M from former directors and third parties [AR24].
  • Pipeline conversion. Converting the ~US$400M pipeline would make AI Nova a material regional player [AR24].
  • Balance-sheet repair. The SCA converts S$34.27M of debt and would eliminate most borrowings [AR24].

Threats

  • Massive dilution. Tranche 1 alone (~1.24bn shares) is ~9x the existing ~137.4M shares [AR24].
  • Regulatory investigation. SGX RegCo is investigating potential listing-rule breaches flagged by FTI [RegCo].
  • Control contest. The October 2026 SGM requisition and proxy dispute could destabilise management mid-pivot [TR].
  • Guarantee exposure. The parent guarantee to the upstream provider creates contingent liabilities [MC 29 Oct 2025].
  • Contingent claims. The RMB334M settlement agreements remain an unprovided contingent claim [AR24].
  • Regulatory and price risk. Malaysian DC restrictions (February 2026) and GPU price deflation [Ind].

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
9 Apr 2025Implementation Agreement with Corpbond [AR24]Framework for debt-for-equity
24 Jun 2025First AI Nova service agreement [MC 29 Oct 2025]First commercial contract
27 Jun 2025High Court claim against 6 ex-directors and 2 third parties [AR24]Seeks HK$91.4M restitution
30 Jun 2025ROTP and Forecast Memorandum re-submitted [AR24]Path to relisting
~Jul 2025Seventh JMO extension to 2 Nov 2025 [AR24]Continuity
9 Jul 2025JM announces the originating claim [RegCo]Disclosure
25 Jul 2025Second service agreement [MC 29 Oct 2025]Customer traction
31 Jul 2025AI Nova US$0.5M loan (7%, convertible at S$0.045) [AR24]Funding
8 Aug 2025AI Nova US$5M loan [AR24]Funding
1 Sep 2025AI Nova US$5M loan (1-year) [AR24]Funding
2 Sep 2025Parent corporate guarantee [MC 29 Oct 2025]Contingent liability at parent
3 Sep 2025AI Nova US$5M loan (3-year) [AR24]Funding
19 Sep 2025GAT sues former CEO Cheng Meng in Bangkok (THB74.97M) [AR23]Recovery action
7 Oct 2025Updated Forecast Memorandum to SGX [AR24]Business-model change
10 Oct 2025Addendum to Implementation Agreement [AR24]Restructuring
27 Oct 2025FY2022 audit report: disclaimer [AR23]Reporting catch-up
28 Oct 2025Share Conversion Agreement signed [AR24]Up to 1.24bn shares at S$0.022
29 Oct 2025Eighth JMO extension to 2 Feb 2026 [MC 5 Nov 2025]Continuity
30 Oct 2025AI Nova 3 × US$1M loans [AR24]Funding
30 Nov 2025First amendment to services agreement [MC 7 Oct 2026]Contract evolution
5 Dec 2025Three independent directors appointed [AR23]Board rebuild
11 Dec 2025FTI findings; SGX RegCo to investigate potential listing-rule breaches [RegCo]Regulatory overhang
7 Jan 2026FY2023 audit report: disclaimer [AR23]Reporting
2 Feb 2026Discharge from judicial management [AR24]Board control restored
18 Feb 2026Bangkok court awards THB500,000 to GAT (vs THB74.97M claimed); GAT to appeal [AR24]Modest recovery
26 Feb 2026Second amendment to services agreement [MC 7 Oct 2026]Contract evolution
10 Mar 2026FY2023 Annual Report published [SGX]Compliance
31 Mar 2026Board re-appointments; Wan Tai Foong joins as Lead ID [AR24]Governance
22 Apr 2026DC Green Development incorporated [Ann 22 Apr 2026]DC strategy
15 May 2026FY2024 AR and results (disclaimer); US$400M pipeline cited [AR24]Strategy reveal
8 Jun 2026Derek Ong Chee Beng appointed Group Financial Controller [MS]Finance function
7 Jul 2026AIDC Investor and HyperEdge Global incorporated [TR 15 Jul 2026]DC strategy
Jul 2026Amended restructuring agreements; US$1M loan agreements terminated [MS], [MC 31 Jul 2026]Restructuring
28 Jul 2026Amended SCA; long-stop date 31 Dec 2026 [MC 31 Jul 2026]Deadline risk
Aug 2026New PRC subsidiary [MS]China expansion
Sep 2026Three new subsidiaries [MS]Expansion
7 Sep 2026Third amendment: services term extended to 60 months [MC 7 Oct 2026]Revenue visibility
~30 Sep 2026~US$65.205M received from customer [MC 7 Oct 2026]Transformational cash inflow
9 Oct 2026Shareholder requisition for SGM (board and CEO change) [TR 9 Oct 2026]Control contest
11 Oct 2026Formal objection to proxies granted by Jia Lijie to Niu Liming [TR 11 Oct 2026]Governance dispute

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

3 charts
Income Statement: Revenue & Gross Profit: Revenue fell from HKD 61.6 Mn in FY2020 to HKD 0 Mn in FY2024.
NutryFarm International Limited — Income Statement: Revenue & Gross Profit
Series (HKD Mn)FY2020FY2021FY2022FY2023FY2024
Revenue61.69904.10
Cost of sales-39.7-68.20-3.90
Gross profit21.930.800.20

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.